Jackson Lab's License Revoked Following Investigation into Oxytocin-Related Deaths of Pregnant Women

Punjab's FDA Revokes Licence of Jackson Laboratories Over Substandard Oxytocin Injection

New Delhi: The Punjab Food and Drugs Administration (FDA) has taken a significant step in ensuring the safety of patients in the region by revoking the manufacturing licence and product permissions of Jackson Laboratories Pvt Ltd. This decision comes after investigations revealed a link between the company's substandard oxytocin injection and the deaths of five pregnant women at New Medical College Hospital in Kota, Rajasthan in May.

According to officials and documents reviewed by Mint, the investigations found that Jackson Laboratories had continued manufacturing oxytocin injections despite receiving stop-production orders three years ago. This blatant disregard for regulatory guidelines and patient safety has led to severe consequences, including the loss of lives.

The FDA's decision to revoke the licence and product permissions of Jackson Laboratories is a significant blow to the company's operations. It is expected that this move will serve as a deterrent to other companies that may be engaging in similar practices, prioritizing profits over patient safety. The FDA's actions demonstrate its commitment to protecting the health and well-being of citizens in Punjab and beyond.

Read also: India Gold ETFs Post First Annual Loss